professional slug
How many doctors can even name the phenomenon described below?
I’ll give a hint: it’s the hallmark of a disease that affects 1.3% of US adults, per CDC. (So docs should know about it!)
#MedSky
How many doctors can even name the phenomenon described below?
I’ll give a hint: it’s the hallmark of a disease that affects 1.3% of US adults, per CDC. (So docs should know about it!)
#MedSky
Nothing has changed since the PFD, afaik, but reinforcement of systemic failings described/quoted in government led Final Delivery Plan - and Justice4ME.uk
Nothing has changed since the PFD, afaik, but reinforcement of systemic failings described/quoted in government led Final Delivery Plan - and Justice4ME.uk
It means 'we f-ked up and don't know what else to do' but nobody but the in-group medics know.
Angry. Yes, I am, still.
Living with unrelenting rage is tiring. Hopefully it is shortening my life expectancy.
It means 'we f-ked up and don't know what else to do' but nobody but the in-group medics know.
Angry. Yes, I am, still.
Living with unrelenting rage is tiring. Hopefully it is shortening my life expectancy.
www.omf.ong
www.omf.ong
Over the last yearish, I’ve become allergic to more than 70 foods. Today I lost soy. I’m not how long I can keep eating at all.
Over the last yearish, I’ve become allergic to more than 70 foods. Today I lost soy. I’m not how long I can keep eating at all.
www.gofundme.com/f/ribhi-and-...
www.gofundme.com/f/ribhi-and-...
- Nacul is testing LDN in Canada
- Scheibenbogen is pursuing immunoadsorption in Germany
- Fluge is trialing daratumumab in Norway
- Sato is testing rituximab again in Japan
- Nacul is testing LDN in Canada
- Scheibenbogen is pursuing immunoadsorption in Germany
- Fluge is trialing daratumumab in Norway
- Sato is testing rituximab again in Japan
Isn't this just called "acountability"?
#abpoli #ableg #cdnpoli
okotoksonline.com/articles/no-...
Will you donate today and help us keep this vital work going? the-sick-times.fundjournalism.org/donate/